Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06887543 · ClinicalTrials.gov registry record · NA
The Impact of Time Restricted Eating on Type 2 Diabetes
A NA study, sponsored by Rockefeller University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT06887543: Clinical Trial NA study, sponsored by Rockefeller University.
NCT06887543 is a NA study that was terminated before completion, run by Rockefeller University. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06887543, a NA study, was terminated before completion, sponsored by Rockefeller University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Time-restricted feeding limits caloric intake to active daytime hours with fasting for 14 to 16 hours. It has shown great promise as a novel intervention for stabilizing blood glucose, reducing weight, and improving cardiovascular disease outcomes. However, this approach has not been tested on people with diabetes, a group that would benefit from improved blood glucose and weight loss. The impact of Time-Restricted Eating on Type 2 Diabetes Study (EaT2D Study) is a randomized six-day weight stable crossover feeding study in the Day Patient/Outpatient unit of The Rockefeller Hospital investigating how the time of day that meals are eaten affects weight, blood sugar and blood pressure. The investigators will compare an early time-restricted eating intervention (80% of calories consumed before 2 pm) to a usual feeding pattern (50% of calories consumed after 4 pm) among 10 persons with type 2 diabetes to determine effects on blood sugar and small molecules found in the blood. Studies have shown benefits of eating during active periods (mornings and early afternoon) for metabolic health (blood sugar, body weight) compared to eating during inactive periods (evening and bedtime). Eating earlier in the day may lead to reduced sugar stores, burning fat for energy, and decreased inflammation when compared to eating later in the day. The investigators will compare the effects of eating earlier during the day for six days versus later in the day for six days, on blood sugar, blood pressure, blood ketones, and other measures of metabolic health in diabetic participants. Studies in animals supports these benefits.
Primary Outcome
Glycemic variation (changes in glucose levels in milligrams per deciliter (mg/dL) will be measured by continuous glucose monitoring (Abbott Freestyle Libre) recorded every 5 minutes for the entire study, as well as 2-hour oral glucose tolerance testing (measured by glucose measurements in mg/dL every 30 minutes for 120 minutes), at baseline testing and upon completion of each arm (Days 1, 8, 15).
Interventions
- OTHER Time restricted eating
- OTHER Meal timing
- OTHER Usual feeding pattern.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2025-05-29 |
| Est. Completion | 2025-08-04 |
| Phase | NA |
Why NCT06887543 stopped before completion
NCT06887543 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 3 interventions - of which Time restricted eating is the first listed.
NCT06887543 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06887543 about?
NCT06887543 is a clinical study titled "The Impact of Time Restricted Eating on Type 2 Diabetes". Time-restricted feeding limits caloric intake to active daytime hours with fasting for 14 to 16 hours. It has shown great promise as a novel intervention for stabilizing blood glucose, reducing weight, and improving cardiovascular disease outcomes. However, this approach has not been tested on peopl...
What is the current status of trial NCT06887543?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2025-05-29. Estimated completion is 2025-08-04.
What interventions are being tested in trial NCT06887543?
The interventions under investigation include: Time restricted eating (OTHER), Meal timing (OTHER), Usual feeding pattern. (OTHER).
Who is sponsoring clinical trial NCT06887543?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06887543's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI